ScienceMakers Toolkit Manual - The History Makers
ScienceMakers Toolkit Manual - The History Makers
ScienceMakers Toolkit Manual - The History Makers
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Science<strong>Makers</strong></strong><br />
Spotlight: Cecil Pickett<br />
Full Name: Cecil Pickett<br />
Born: October 5, 1945<br />
Place: Canton, IL<br />
Parents: Florence Pickett<br />
Charles Pickett<br />
Spouse: Shirley Pickett<br />
Education: Canton High School - Canton, IL (1967)<br />
University of California, Berkley - Berkeley, CA<br />
(B.S. Biology, 1976)<br />
University of California, Los Angeles - Los Angeles, CA<br />
(Ph.D. Biology, 1976)<br />
Type of Science: Biology, Pharmacology<br />
Achievements: Led discovery efforts for important and pioneering drugs for asthma,<br />
aarthritis and high cholesterol including Sinulair and Vioxx<br />
Named one of the 50 Most Powerful Black Executives by<br />
Fortune Magazine (2002)<br />
Biography<br />
Pharmaceutical researcher Cecil Pickett was born on October 5, 1945, in Canton, Illinois,<br />
to Charles Pickett, a farmer, and Florence Pickett, a homemaker. In high school, Pickett’s<br />
favorite subjects were math, chemistry, and biology, which led him to major in biology at the<br />
University of California, Berkeley, where he received his B.S. degree in 1971. After completing<br />
his undergraduate studies, Pickett took on a teaching fellowship at the University of California Los<br />
Angeles, where he was a student of Dr. Joseph Cascarano and earned his Ph.D. in biology in 1976.<br />
Upon graduating with his doctorate, Pickett became a visiting lecturer in biology at the Howard<br />
University College of Medicine before joining the staff of Merck Research Laboratories as head of<br />
research in 1978. At Merck, Pickett led the discovery efforts for important and pioneering drugs for<br />
asthma, arthritis, and high cholesterol, including Singulair and Vioxx. With Merck, Pickett transferred<br />
to Montreal, Canada, in 1988, where he headed drug discovery at the Merck Frosst Center<br />
for <strong>The</strong>rapeutic Research. In 1993, Pickett was hired to be the Executive Vice President of Discovery<br />
Research at Schering-Plough Research Institute, where he continued his reputation for innovative<br />
research and expanded the company’s drug discovery program, which produced AIDS and<br />
107